Clinical trial
Metabotypes in the Urinary Excretion of Flavan-3-ol Metabolites
NCT04124016 is registered in ClinicalTrials.gov with University of Parma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Metabotypes in the Urinary Excretion of Flavan-3-ol Metabolites
- Lead sponsor
- University of Parma
- Phase
- Not applicable
- Overall status
- Suspended
- Start date
- September 2, 2019
- Completion date
- December 27, 2022
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diet modification